MARKET

OTLC

OTLC

Oncotelic Therapeutics Inc
OTCMQB
0.041
-0.001
-1.91%
Closed 15:42 07/02 EDT
OPEN
0.044
PREV CLOSE
0.042
HIGH
0.044
LOW
0.040
VOLUME
272.25K
TURNOVER
11.33K
52 WEEK HIGH
0.108
52 WEEK LOW
0.030
MARKET CAP
18.22M
P/E (TTM)
0.074
1D
5D
1M
3M
1Y
5Y
1D
Oncotelic CEO, Chairman Trieu Vuong reports purchase of 240,000 common shares valued at $10,344
PUBT · 2d ago
Oncotelic Therapeutics Enters New Convertible Note Financing
TipRanks · 5d ago
Oncotelic evaluates IV everolimus candidate Sapu003 in Phase 1b trial for advanced solid tumors
PUBT · 6d ago
Weekly Report: what happened at OTLC last week (0622-0626)?
Weekly Report · 6d ago
Oncotelic Therapeutics Chairman and CEO Trieu Vuong acquires $11,475 of common shares
PUBT · 06/25 00:38
Oncotelic CFO Amit Shah reports purchase of common shares worth $1,000
PUBT · 06/22 20:31
Weekly Report: what happened at OTLC last week (0615-0619)?
Weekly Report · 06/22 09:11
Oncotelic collaborates with TechForce Robotics on AI-enabled GMP manufacturing platform
PUBT · 06/18 12:09
More
About OTLC
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small-molecule injectable drugs for the treatment of cancer. The Company has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.

Webull offers Oncotelic Therapeutics Inc stock information, including OTCMQB: OTLC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLC stock methods without spending real money on the virtual paper trading platform.